We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Daily Journal
DJCO
$819M
| $278K | ﹤0.01% |
1,208
-195
| -14% | -$45.9K |
|
|
SIGM
2502
DELISTED
Sigma Designs Inc
SIGM
| $277K | ﹤0.01% |
39,881
-6,461
| -14% | -$40.5K |
|
2503
First Bancorp
FNLC
$394M
| $275K | ﹤0.01% |
10,106
-1,950
| -16% | -$58.2K |
|
|
HCCI
2504
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $275K | ﹤0.01% |
12,642
-2,210
| -15% | -$44.5K |
|
|
TBNK
2505
DELISTED
Territorial Bancorp Inc.
TBNK
| $272K | ﹤0.01% |
8,818
-1,491
| -14% | -$47.1K |
|
|
GNC
2506
DELISTED
GNC Holdings, Inc.
GNC
| $272K | ﹤0.01% |
73,686
-11,175
| -13% | -$70.2K |
|
|
FBMS
2507
DELISTED
The First Bancshares, Inc.
FBMS
| $271K | ﹤0.01% |
7,937
-1,192
| -13% | -$38K |
|
|
CTO
2508
CTO Realty Growth
CTO
$820M
| $269K | ﹤0.01% |
15,624
-2,770
| -15% | -$45.2K |
|
2509
Green Brick Partners
GRBK
$3.03B
| $269K | ﹤0.01% |
23,800
-3,900
| -14% | -$42.8K |
|
2510
Pacific Biosciences
PACB
$460M
| $267K | ﹤0.01% |
101,110
-7,474
| -7% | -$26.2K |
|
2511
Limoneira
LMNR
$241M
| $266K | ﹤0.01% |
11,868
-2,050
| -15% | -$47.5K |
|
|
PENG
2512
Penguin Solutions Inc
PENG
$2.64B
| $266K | ﹤0.01% |
15,792
-13,134
| -45% | -$208K |
|
2513
Regional Management Corp
RM
$297M
| $265K | ﹤0.01% |
10,077
-1,900
| -16% | -$46.5K |
|
2514
TechTarget
TTGT
$325M
| $265K | ﹤0.01% |
19,030
-3,500
| -16% | -$45.6K |
|
|
FFKT
2515
DELISTED
Farmers Capital Bank Corp
FFKT
| $265K | ﹤0.01% |
6,888
-1,300
| -16% | -$53.8K |
|
2516
Natera
NTRA
$38.6B
| $264K | ﹤0.01% |
29,379
-5,549
| -16% | -$60K |
|
2517
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $263K | ﹤0.01% |
11,950
-3,179
| -21% | -$74.4K |
|
2518
Calix
CALX
$2.22B
| $263K | ﹤0.01% |
44,273
-7,439
| -14% | -$45K |
|
2519
Corbus Pharmaceuticals
CRBP
$168M
| $263K | ﹤0.01% |
1,235
-287
| -19% | -$61.4K |
|
2520
Rockwell Medical
RMTI
$28M
| $263K | ﹤0.01% |
411
-78
| -16% | -$54.9K |
|
2521
IDT Corp
IDT
$1.64B
| $261K | ﹤0.01% |
29,119
-3,486
| -11% | -$38.2K |
|
2522
Utah Medical Products
UTMD
$222M
| $261K | ﹤0.01% |
3,209
-602
| -16% | -$47K |
|
|
BRG
2523
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $261K | ﹤0.01% |
25,798
-4,031
| -14% | -$44.8K |
|
|
ENTL
2524
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $261K | ﹤0.01% |
10,713
-2,060
| -16% | -$39.6K |
|
|
TRK
2525
DELISTED
Speedway Motorsports, Inc.
TRK
| $259K | ﹤0.01% |
13,708
-3,035
| -18% | -$61.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.